Functional evaluation of Duchenne muscular dystrophy: proposal for a protocol
- PMID: 6762370
- DOI: 10.1007/BF02043581
Functional evaluation of Duchenne muscular dystrophy: proposal for a protocol
Abstract
A protocol for the evaluation of functional activities in subjects with Duchenne muscular dystrophy (DMD) was designed. The aim of our study was to define objective clinical criteria for the evaluation both of the clinical status of the patient and of the natural history of the illness itself. A protocol with such criteria is particularly necessary when testing the efficacy of treatment. 43 still-ambulant children with DMD between the ages of 3.10 yr and 10.4 yr were examined. Of this number 19 children were evaluated every 4 months over a period of 12 months; of these 14 formed part of a randomized double blind trial with L-carnitine (1.2-1.8 g/day) versus placebo.
Similar articles
-
Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine.Muscle Nerve. 1984 Sep;7(7):535-41. doi: 10.1002/mus.880070704. Muscle Nerve. 1984. PMID: 6399927 Clinical Trial.
-
A double-blind placebo controlled trial of diltiazem in Duchenne dystrophy.Klin Wochenschr. 1988 Jul 1;66(13):565-70. doi: 10.1007/BF01720830. Klin Wochenschr. 1988. PMID: 2463406 Clinical Trial.
-
Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy.Neuromuscul Disord. 1995 May;5(3):233-41. doi: 10.1016/0960-8966(94)00048-e. Neuromuscul Disord. 1995. PMID: 7633189 Clinical Trial.
-
Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.JAMA Neurol. 2016 Jan;73(1):111-6. doi: 10.1001/jamaneurol.2015.3537. JAMA Neurol. 2016. PMID: 26594870 Review.
-
Therapeutic trials on progressive muscular dystrophy.Intern Med. 1992 Jul;31(7):841-6. doi: 10.2169/internalmedicine.31.841. Intern Med. 1992. PMID: 1450492 Review.
Cited by
-
Identification of a mutation in the promoter region of the dystrophin gene in a patient with atypical Becker muscular dystrophy.Hum Genet. 1991 Dec;88(2):195-9. doi: 10.1007/BF00206071. Hum Genet. 1991. PMID: 1757094
-
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.J Med Genet. 1993 Sep;30(9):728-36. doi: 10.1136/jmg.30.9.728. J Med Genet. 1993. PMID: 8411067 Free PMC article.
-
Pathomechanics of Gowers' sign: a video analysis of a spectrum of Gowers' maneuvers.Clin Orthop Relat Res. 2012 Jul;470(7):1987-91. doi: 10.1007/s11999-011-2210-6. Epub 2011 Dec 28. Clin Orthop Relat Res. 2012. PMID: 22203329 Free PMC article.
-
Ambient floor vibration sensing advances the accessibility of functional gait assessments for children with muscular dystrophies.Sci Rep. 2024 May 11;14(1):10774. doi: 10.1038/s41598-024-60034-5. Sci Rep. 2024. PMID: 38729999 Free PMC article.
-
Genetic and clinical correlations of Xp21 muscular dystrophy.J Inherit Metab Dis. 1992;15(4):551-64. doi: 10.1007/BF01799614. J Inherit Metab Dis. 1992. PMID: 1528016 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical